COVID-19 Vaccine Adverse Reactions
Update on publication status The Commission on Human Medicine (CHM) has advised that given the end of the Autumn 2022 booster campaign and the stable safety profile of the COVID-19 vaccines, the MHRA should transition to routine data publication and communication of safety concerns for COVID-19 vaccines. This report is therefore the last regular publication of the Summary of Yellow Card reporting for COVID-19 vaccines. Robust safety monitoring and surveillance of any COVID-19 vaccines used in the UK will continueREAD MORE…READ MORE…









